[ad_1]
(AOF) – Adocia announces the appointment of Mathieu-William Gilbert as Chief Financial Officer. This clinical-stage biotech specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity specifies that he succeeds Valérie Danaguezian, who has held this position since 2005. Mathieu-William Gilbert joined the company in May 2024 as Chief Operating Officer after a career spanning more than fifteen years at the Novo Nordisk laboratory.
In his new role, Mathieu-William Gilbert will oversee administrative and financial functions, investor relations, legal affairs and human resources. He is also a member of the executive committee and acts as secretary general of the board of directors.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from sources it considers the most reliable. However, the reader remains solely responsible for their interpretation and the use of the information made available to him. Thus, the reader must hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article? Share it with your friends using the buttons below.
[ad_2]
Source link -85